Rabid about
rabies – why me?
As a neurobiologist, I’ve been interested and intrigued about
rage, emotions, & rabies for many years.
But without a clear model to work on, there’s never been an experimental
approach to use to study rage. As I
mentioned earlier, the most promising model, septal rage, disappears after a
short time leaving us with nothing to interrogate. In terms of treating rabies, there is a very
good prophylactic and post-exposure (but pre-infection) vaccine that vastly
reduces the chance of infection. So,
there isn’t a huge (in comparison to, say, Alzheimer’s disease) patient
population demanding the time and resources of academic or pharmaceutical
researchers. So, I’ve worked on many
other projects and neuropsychiatric disorders.
For me, that all came to a crashing halt in 2005 when a boy,
Zachary Jones, died from rabies just a few miles from where I live! He was bitten in his sleep by a rabid
bat. To him, it was just a dead bat on
the floor and he may not even have noticed the bite; certainly nothing to tell
his parents about. When the symptoms of
rabies infection appeared, it was too late to save him. Even though the best treatment, the Milwaukee
protocol, was used, there really is nothing we can do to treat rabies
infection. Zachary died.
That made me mad! How
could we have let this happen with all the modern tools and treatments that
medicine and neurobiology have to offer?
Of course, at the time I was engaged in more immediate projects and
still had no idea of how to engage rabies.
But, I began to re-read and read more about the rabies virus. I found that its unique properties do make it
amenable to understanding. There is a
straight-forward series of studies that will identify the rabies receptor. I tried to garner interest within Pharma, but
no one was interested enough to listen.
Neuroscience research groups, often made up of younger investigators who
have never read about how the Papez circuit was discovered, if they’ve even
heard of the Papez circuit at all, said that rabies is an infectious disease,
so I needed to talk with the infectious disease or immunology department. And the infectious disease/immunology
departments said, that rabies only kills about 50,000 people a year, while HIV,
etc., kill many, many more, and we don’t have the resources to work on all the
viral diseases. As a lone pharmaceutical
researcher, without academic ties, I don’t have much access to government
grants either.
New treatments for rabies infection are important, and
treatments that would block the effects of the virus after infection are
critical. But, in addition, and in some
ways more critical is to understand and find treatments for human lyssants, for
outbursts of rage that disable so many victims and hurt so many others. Rage attacks come through many
neuropsychiatric disorders as I’ve noted in earlier blogs. But, as we have no central, biological
understanding of rage, they are shoved into a vast array of disorders where
they are a secondary, comorbid condition without any hope of treatment. And then there’s simply the fact that
lyssantic behavior is a normal part of being human and control of it a vital
part of becoming an adult member of social society. As long as we don’t know where rage comes
from, we will continue to depict it as supernatural vampires and werewolves;
creatures, feelings, and behaviors apparently beyond our control. As long as we use that excuse, we won’t
really become the humans that we actually are.
For all these reasons, I am rabid about discovering the
target, the receptor, by which the rabies virus releases our inner lyssant, and
why I’m determined that we better understand ourselves, and better protect
ourselves from the virus and from ourselves when necessary. We have the tools and reagents to discover
the rabies receptor. The path forward is
straight-forward, but it is not inexpensive.
Help me!
No comments:
Post a Comment